Ranjini K Sundaram

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Dna Damage Response

Renal Cell Carcinoma

Top Venues

Molecular cancer therapeutics

Molecular cancer research : MCR

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Katelyn J Noronha, Karlie N Lucas, Sateja Paradkar, Joseph Edmonds, Sam Friedman, Matthew A Murray, Samantha Liu, Dipti P Sajed, Chana Sachs, Joshua Spurrier, Mitch Raponi, Jiayu Liang, Hao Zeng, Ranjini K Sundaram, Brian M Shuch, Juan C Vasquez, Ranjit S Bindra
NAPRT silencing in FH-deficient renal cell carcinoma confers therapeutic vulnerabilities via NAD+ depletion. Molecular cancer research : MCR (2024)
Matthew A Murray, Katelyn J Noronha, Yazhe Wang, Anna P Friedman, Sateja Paradkar, Hee Won Suh, Ranjini K Sundaram, Charles Brenner, W Mark Saltzman, Ranjit S Bindra
Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors. Molecular cancer therapeutics 23 (8) (2024)
Matthew A Murray, Katelyn J Noronha, Yazhe Wang, Anna P Friedman, Sateja Paradkar, Hee Won Suh, Ranjini K Sundaram, Charles Brenner, W Mark Saltzman, Ranjit S Bindra
Exploiting Metabolic Defects in Glioma with Nanoparticle Encapsulated NAMPT Inhibitors. Molecular cancer therapeutics (2024)
Matthew A Murray, Katelyn J Noronha, Yazhe Wang, Anna P Friedman, Sateja Paradkar, Hee Won Suh, Ranjini K Sundaram, Charles Brenner, W Mark Saltzman, Ranjit S Bindra
Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors. Molecular cancer therapeutics 23 (8) (2024)
Matthew A Murray, Katelyn J Noronha, Yazhe Wang, Anna P Friedman, Sateja Paradkar, Hee Won Suh, Ranjini K Sundaram, Charles Brenner, W Mark Saltzman, Ranjit S Bindra
Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors. Molecular cancer therapeutics 23 (8) (2024)
Matthew A Murray, Katelyn J Noronha, Yazhe Wang, Anna P Friedman, Sateja Paradkar, Hee Won Suh, Ranjini K Sundaram, Charles Brenner, W Mark Saltzman, Ranjit S Bindra
Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors. Molecular cancer therapeutics 23 (8) (2024)
Kingson Lin, Susan E Gueble, Ranjini K Sundaram, Eric D Huseman, Ranjit S Bindra, Seth B Herzon
Mechanism-based design of agents that selectively target drug-resistant glioma. Science (New York, N.Y.) 377 (6605) (2022)
Ukhyun Jo, Yasuhisa Murai, Keli K Agama, Yilun Sun, Liton Kumar Saha, Xi Yang, Yasuhiro Arakawa, Sophia Gayle, Kelli Jones, Vishwas Paralkar, Ranjini K Sundaram, Jinny Van Doorn, Juan C Vasquez, Ranjit S Bindra, Woo Suk Choi, Yves Pommier
TOP1-DNA Trapping by Exatecan and Combination Therapy with ATR Inhibitor. Molecular cancer therapeutics 21 (7) (2022)